CN107501142B - Restore chemical linkers and its preparation and purposes of the response type containing double disulfide bond - Google Patents
Restore chemical linkers and its preparation and purposes of the response type containing double disulfide bond Download PDFInfo
- Publication number
- CN107501142B CN107501142B CN201710756890.2A CN201710756890A CN107501142B CN 107501142 B CN107501142 B CN 107501142B CN 201710756890 A CN201710756890 A CN 201710756890A CN 107501142 B CN107501142 B CN 107501142B
- Authority
- CN
- China
- Prior art keywords
- disulfide bond
- double
- response type
- containing double
- chemical linkers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000126 substance Substances 0.000 title claims abstract description 37
- 230000004044 response Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 230000009467 reduction Effects 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 230000004043 responsiveness Effects 0.000 claims abstract description 14
- 230000002195 synergetic effect Effects 0.000 claims abstract description 6
- -1 amino, hydroxyl Chemical group 0.000 claims description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 48
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 35
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 28
- 229910052799 carbon Inorganic materials 0.000 claims description 21
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 20
- 230000015572 biosynthetic process Effects 0.000 claims description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- 238000003786 synthesis reaction Methods 0.000 claims description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000005864 Sulphur Substances 0.000 claims description 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 11
- 229920001184 polypeptide Polymers 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 125000001118 alkylidene group Chemical group 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 239000008363 phosphate buffer Substances 0.000 claims description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 230000033228 biological regulation Effects 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 235000019441 ethanol Nutrition 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000000539 dimer Substances 0.000 claims description 3
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 claims description 3
- 229960001051 dimercaprol Drugs 0.000 claims description 3
- HCRCMMQGSYNMIC-UHFFFAOYSA-N 1-aminopropane-1,2-dithiol Chemical compound CC(S)C(N)S HCRCMMQGSYNMIC-UHFFFAOYSA-N 0.000 claims description 2
- AIVVKKOTAISCNQ-UHFFFAOYSA-N 2,3-bis(sulfanyl)propanoic acid Chemical compound OC(=O)C(S)CS AIVVKKOTAISCNQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 239000000599 controlled substance Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 15
- 229940079593 drug Drugs 0.000 abstract description 13
- 239000003638 chemical reducing agent Substances 0.000 abstract description 10
- 230000001603 reducing effect Effects 0.000 abstract description 7
- 238000012377 drug delivery Methods 0.000 abstract description 3
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 229940125645 monoclonal antibody drug Drugs 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 62
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 36
- 239000005711 Benzoic acid Substances 0.000 description 31
- 239000007787 solid Substances 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 29
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 28
- 235000010233 benzoic acid Nutrition 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 20
- 239000000523 sample Substances 0.000 description 20
- 150000001721 carbon Chemical group 0.000 description 16
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 125000003118 aryl group Chemical group 0.000 description 14
- 229960003180 glutathione Drugs 0.000 description 14
- 102000004377 Thiopurine S-methyltransferases Human genes 0.000 description 13
- 108090000958 Thiopurine S-methyltransferases Proteins 0.000 description 13
- 125000005647 linker group Chemical group 0.000 description 13
- 238000005160 1H NMR spectroscopy Methods 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 12
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 11
- 229940002612 prodrug Drugs 0.000 description 11
- 239000000651 prodrug Substances 0.000 description 11
- 239000002585 base Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 238000003384 imaging method Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000003513 alkali Substances 0.000 description 9
- 230000003197 catalytic effect Effects 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 229910052736 halogen Inorganic materials 0.000 description 8
- 150000002367 halogens Chemical group 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 235000019400 benzoyl peroxide Nutrition 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- 235000011121 sodium hydroxide Nutrition 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000007445 Chromatographic isolation Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- CWXZAJNUTOBAOI-UHFFFAOYSA-N 1-(2,3-dimethoxyphenyl)-2-hydroxy-2-phenylethanone Chemical compound COC1=CC=CC(C(=O)C(O)C=2C=CC=CC=2)=C1OC CWXZAJNUTOBAOI-UHFFFAOYSA-N 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- FAXUEHQTQCURLQ-UHFFFAOYSA-N CCC(C(S)=C(C=C1)C(C)=O)=C1C(O)=O Chemical compound CCC(C(S)=C(C=C1)C(C)=O)=C1C(O)=O FAXUEHQTQCURLQ-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001336 alkenes Chemical class 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 239000004342 Benzoyl peroxide Substances 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000004847 absorption spectroscopy Methods 0.000 description 3
- 238000007259 addition reaction Methods 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- SDJHDRMYZQFJJO-UHFFFAOYSA-N ethanethioic s-acid;potassium Chemical compound [K].CC(S)=O SDJHDRMYZQFJJO-UHFFFAOYSA-N 0.000 description 3
- 125000001072 heteroaryl group Chemical group 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- KGKAYWMGPDWLQZ-UHFFFAOYSA-N 1,2-bis(bromomethyl)benzene Chemical compound BrCC1=CC=CC=C1CBr KGKAYWMGPDWLQZ-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ZTODWMBSWAUREH-UHFFFAOYSA-N 2,5-bis(ethenyl)benzoic acid Chemical compound C=CC1=CC(=C(C=C1)C=C)C(=O)O ZTODWMBSWAUREH-UHFFFAOYSA-N 0.000 description 2
- LXHVCQJGEYIDRJ-UHFFFAOYSA-N 3,5-bis(ethenyl)benzoic acid Chemical compound OC(=O)C1=CC(C=C)=CC(C=C)=C1 LXHVCQJGEYIDRJ-UHFFFAOYSA-N 0.000 description 2
- IHPXZYAAEDIRIW-UHFFFAOYSA-N 3-(2-acetylsulfanylethyl)-2-methylbenzoic acid Chemical compound C(C)(=O)SCCC=1C(=C(C(=O)O)C=CC=1)C IHPXZYAAEDIRIW-UHFFFAOYSA-N 0.000 description 2
- QNPJPNFLUQOOFK-UHFFFAOYSA-N 3-(2-acetylsulfanylethyl)-5-(bromomethyl)benzoic acid Chemical compound C(C)(=O)SCCC=1C=C(C(=O)O)C=C(C=1)CBr QNPJPNFLUQOOFK-UHFFFAOYSA-N 0.000 description 2
- DXYUMUNLDRQTNO-UHFFFAOYSA-N 3-ethenyl-5-methylbenzoic acid Chemical compound CC=1C=C(C(=O)O)C=C(C=1)C=C DXYUMUNLDRQTNO-UHFFFAOYSA-N 0.000 description 2
- QEDXSHCYPROEOK-UHFFFAOYSA-N 3-phosphanylpropanoic acid Chemical class OC(=O)CCP QEDXSHCYPROEOK-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 239000012964 benzotriazole Substances 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- PIZHFBODNLEQBL-UHFFFAOYSA-N 2,2-diethoxy-1-phenylethanone Chemical compound CCOC(OCC)C(=O)C1=CC=CC=C1 PIZHFBODNLEQBL-UHFFFAOYSA-N 0.000 description 1
- QGHDLJAZIIFENW-UHFFFAOYSA-N 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxy-3-prop-2-enylphenyl)propan-2-yl]-2-prop-2-enylphenol Chemical group C1=C(CC=C)C(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C(CC=C)=C1 QGHDLJAZIIFENW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004870 Styrax Substances 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- IIYFAKIEWZDVMP-UHFFFAOYSA-N linear paraffin C13 Natural products CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- KTBJFVJBDRTXMD-UHFFFAOYSA-N methanethioyl chloride Chemical compound ClC=S KTBJFVJBDRTXMD-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- ALDITMKAAPLVJK-UHFFFAOYSA-N prop-1-ene;hydrate Chemical compound O.CC=C ALDITMKAAPLVJK-UHFFFAOYSA-N 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000005059 solid analysis Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 108010001535 sulfhydryl oxidase Proteins 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B11/00—Diaryl- or thriarylmethane dyes
- C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
- C09B11/06—Hydroxy derivatives of triarylmethanes in which at least one OH group is bound to an aryl nucleus and their ethers or esters
- C09B11/08—Phthaleins; Phenolphthaleins; Fluorescein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/02—Monothiocarboxylic acids
- C07C327/04—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C327/06—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/22—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D341/00—Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5456—Arylalkanephosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Materials Engineering (AREA)
- Optics & Photonics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Restore chemical linkers and its preparation and purposes of the response type containing double disulfide bond, it is related to the formed chemical linkers with double disulfide bond of the compound with double sulfydryls, it constructs the dynamic covalent linkage with unique redox responsiveness based on the synergistic effect between mutually incoherent double disulfide bond.The covalent linkage has the redox responsiveness completely different with traditional single disulfide bond;Under low-reductant concentration or extracellular conditions, with the stability of superelevation, and quick reduction fracture can occurs under the conditions of strong reducing properties in the cell etc. in it.It is expected to be applied to drug release and bio-sensing field, constructs redox response type drug delivery system, such as monoclonal antibody-drug coupling body.
Description
Technical field
The present invention relates to the formed chemical linkers with double disulfide bond of the compound with double sulfydryls, especially
It is related to restoring chemical linkers and its preparation and purposes of the response type containing double disulfide bond.
Background technique
Most of drug, the effective therapeutic agent especially in cancer chemotherapy often show internal urgency in the prior art
Property toxicity, has that toxic side effect is larger during practical application, which has limited their applications.Therefore new drug
Focus on that exploitation more needs to have tumour cell with bigger with safer specific treatment agent, especially antitumor agent
Effect property, but the quantity and seriousness of these side effects of pharmaceutical drugs are reduced simultaneously.In addition, the another kind of existing drug the disadvantage is that they
Stability in vivo in circulation is insufficient, after most drugs enter in vivo, with blood circulation reach human body each organ and
Tissue, wherein the part for eventually arriving at destination organization is less, most of drug decomposes in the circulating cycle, and accumulates in human health group
In knitting, therapeutic effect is not achieved.
Part researchs and develops the form that new drug is pro-drug.Pro-drug, both prodrug was active medicine chemistry
Be converted to itself inactive or low activity derivative, using chemistry or enzyme effect before or after reaching action site
It is converted to parent drug in vivo.To reduce toxicity, this transformation is normally limited to site of action or target tissue rather than recycles
System or non-target tissue.
Prodrug is prepared to change the pharmacokinetics of drug, improves dissolubility, stability, reduces toxicity, increases specificity
With the duration for the pharmacological effect for increasing drug.Increase drug absorption, distribution, bioconversion by changing pharmacokinetics
And excretion, to increase the bioavilability of drug.In prodrug design, it is important to consider that following factor: carrier attachment
Selection;Prodrug is necessary for reversible or bio-reversible medicaments derivative and inactive or specific activity ingredient activity is low;Target
The specificity of point and compatibility etc..About prodrug reference can be made to such as Rautio, J.et al., Nature Reviews
DrugDiscovery 7.3 (2008): 255-70 and Chari, Ravi V.J.et al., Angewandte Chemie
International Edition 53.15(2014):3796-827。
Currently, the connecting key that attachment (Linker) uses in prodrug mainly has ester bond, amido bond, acylhydrazone key, thioether bond
With the covalent bonds such as disulfide bond.Wherein, disulfide bond is a kind of covalent linkage being widely used.Disulfide bond is important in life entity
Chemical bond, under the reducing conditions, it may occur that fracture;Under the action of other thiol compounds, it may occur that bimolecular nucleophilic takes
Generation reaction generates new disulfide bond and thiol molecule.Disulfide bond is the most common dynamic covalent bond in protein structure, not only
Can effectively regulation protein folding process, and can be made a response for redox environments different in organism.
The responsiveness of disulfide bond is mainly reflected in it can generate new disulfide bond between thiol molecule by bimolecular nucleophilic subsititution
And thiol molecule.
Due to usually containing sulfydryl in biomolecule, such as the cysteine residues on polypeptide and protein, it is especially advantageous for repairing
Decorations, construct the Biofunctional materials of redox response type, such as drug delivery system and activated form fluorescence imaging in which can be convenient
Probe etc..In the system for being mostly based on disulfide bond building, disulfide bond is straight mainly as the connecting key of redox response type
Body and loading molecule (drug or fluorescence probe) are carried in succession, see, for example, Santra, Santimuk μ L et al., Journal
of the American Chemical Society 133.41(2011):16680–16688.These systems are in biotic environment
In responsiveness depend primarily on the breaking kinetics of disulfide bond in the environment.It is rung to improve the redox based on disulfide bond
The biological property of type system is answered, the stability of disulfide bond, which must pass through, subtly to be regulated and controled, and reaches target position to avoid disulfide bond
It is broken in advance (such as in blood circulation and extracellular environment) before point;Also to guarantee it after reaching target site simultaneously
(as intracellular) can be broken rapidly, and discharge loading molecule.
Currently, there are mainly two types of the stability that method can be applied to regulation disulfide bond: introducing steric hindrance and improve disulfide bond
Stability;Change its stability of disulfide bond study on microenvironment regulation, referring to Kellogg, Brenda A.et al., Bioconjugate
Chemistry 22.4(2011):717-27.Although these methods can be existed with the stability of accuracy controlling disulfide bond, disulfide bond
The difference of stability but is difficult to be regulated and controled in different redox environments.For traditional single disulfide bond, in redox
Response mode in environment is based on disulfide bonds rate and reducing agent (thiol molecule, as between glutathione GSH) concentration
Linear relationship.The stability for improving disulfide bond, although reducing the Drug Conjugates degree that cycle interruption is split in vivo,
Also it affects it and reaches the efficiency discharged after destination organization.The chemical formula of traditional single disulfide bond is as follows:
Therefore, in practical applications, nonlinear response mode is even more important, i.e., disulfide bond under low-reductant concentration or
Need that there is higher stability in the environment of week reduction, and can more rapidly in high reductant concentration or the environment of strong reducing property
Generation reduction fracture.This nonlinear response type can not be realized always in traditional single disulfide bond, significantly limit
The application potential of Biofunctional materials based on disulfide bond building.Wu et al. in Zhai, LX, et al.Chem.Eur.J.,
20.52 (2014): proposing a kind of connecting key form based on two disulfide bond in 17507-14, can be mutual by two
The disulfide bond of synergistic effect, which constitutes, a kind of has the characteristics that the connecting key of nonlinear response.However, two acyl of naphthalene used in it is sub-
Amine molecule (NDI) parent has some disadvantages: poor in polarity and the dissolubility in nonpolar solvent;Volume is larger, connects to it
There may be other effects for the load connect;Responsiveness cannot in further regulation, can not further satisfaction novel prodrugs etc. answer
Demand.
Need to construct above-mentioned double disulfide bond attachment systems, basis is the structure for constituting the monomer molecule of its attachment
In there are double mercapto functional groups.In nature and current research, more double thiol molecules are had existed.Wherein, natural
Molecule present in boundary has lipoic acid, dithiothreitol (DTT), 2,3- dimercaprol dimercaptopropanol and 1,2- dimercaptoethane etc.;Furthermore this kind of knot
Structure is also widely present in polypeptide, protein, and Cys-Xaa-Cys and Cys-Xaa-Xaa- is normally behaved as in polypeptide sequence
The form of Cys (wherein Cys is cysteine, and Xaa is a kind of any other natural amino acid).Under study for action, there are double sulfydryls
The molecule of structure is typically based on the dynamic property of disulfide bond, for constructing in dynamic combinatorial chemistry library.Point being more commonly used
Son is carboxyl diphenyl disulfide phenol, bis- (thiopurine methyltransferase) benzoic acid of 3,5-, referring to West, K.R., et al., Organic Letters
7.13 (2005): 2615-8 and Otto, S, et al., Science 297.5581 (2002): 590-3.
Although the above molecule meets the basic demand for constituting double disulfide bond attachments, wherein most can not be formed
Double disulfide bond attachments of synergistic effect.The concertedness of sulfydryl is directly influenced by the space structure near sulfydryl, including mercapto
Distance between base between the rigidity and sulfydryl of molecular skeleton.Inappropriate structure, which will lead to, can not form synergistic effect, generate too low
Or excessively high stability: too low stability causes attachment to be directly broken in the circulating cycle;Crossing high stability causes attachment to reach
It can not be broken after target site.Therefore, the molecular skeleton for connecting two mercapto groups need to have certain rigidity, and two sulfydryls
Between spacing require more than the bond distance of disulfide bond.
Some double sulfhydryl compounds, the carboxyl diphenyl disulfide phenol and 3 such as before told, bis- (thiopurine methyltransferase) benzoic acid of 5-, autoxidation
When thermodynamically stable product be tripolymer or polymer, and some double sulfhydryl compounds directly tend to form the two of intramolecular
Sulfide linkage inner ring, the yield that may eventually lead to the formation of the dimer with double disulfide bond are lower.And many common double sulfhydryl compounds,
Also lack the site that can further react with modification, make it that can not be used to constitute attachment.
It is polysubstituted from common sense and literature cited it is found that phenyl ring is a kind of suitably with the rigid parent of multidigit point
Raw material is easy to get.Phenyl ring is connected to for sulfydryl and the case where sulfydryl is connected to benzyl position, there is suitable synthetic method.But work as mercapto
With more than one, phenyl ring parent interval carbon atom and when situation that the carbon atom band that is connected with sulfydryl is substituted, general synthesis makes base
Halogen substitution technique is simultaneously not suitable for.Because this kind of site can not replace progress halogenated by benzyl position free radical, and contain conjunction
The polysubstituted phenyl ring parent stock of suitable modification group is also prohibitively expensive or can not directly buy, the space limited its application.
In addition, also needing to consider the hydrophilic and hydrophobic of molecule itself, dissolubility, toxicity, stabilization when constructing this kind of attachment
Property and structure, these properties all affect whole system.The most ideal situation is that the double disulfide bond attachments introduced only have also
The property of original response is all smaller to the other influences of loaded article and composition.
The delivering and release of prodrug are still the major issue for needing to solve, and wherein the optimization of attachment is a key,
Although this field has been achieved for centainly being in progress, remain on and need to develop improved attachment, regulate and control attachment stability and
Responsiveness, to meet the demand of different drug delivery and release.
Summary of the invention
It is an object of the invention to for existing single insufficient and rigid naphthalimide molecule of disulfide bond medicine-carried system stability
The water-soluble poor defect that can not further apply of double disulfide bond systems of building, provides can be used for sensing and delivering, volume
Smaller, water-soluble and responsiveness is good, with realize can the reduction response type of reduction response release of accuracy controlling contain double disulfide bond
Chemical linkers and preparation method thereof and purposes.
A kind of double sulfhydryl compounds can be connected by double sulfydryls with itself or other substances with double sulfydryls, and formation has
The compound of double disulfide bond.
A method of disulfide bond redox responsiveness being regulated and controled based on synergistic effect between key, the method includes providing one
Chemical linkers and preparation method thereof of the class containing double disulfide bond, the method can solve traditional single disulfide bond in biotic environment
In stability and redox responsiveness (such as blood circulation, extracellular and intracellular environment etc.) be difficult to both with defect, institute
State double disulfide bond compounds in method as attachment controlled drug delivering, release and bio-sensing purposes.
The chemical general formula of a kind of double sulfhydryl compounds is as follows:
Wherein Ar indicates aryl or heteroaryl;R1Indicate singly-bound, alkylidene, substituted alkylene;Y indicate carboxyl, amino,
Hydroxyl, azido, sulfonic group, halogen;R2Independently selected from hydrogen, alkyl, alkoxy, aryl, heteroaryl, halogen, nitro, cyanogen
Base, can have all identical chemical structures or all different chemical structure or in which any several there is phase
Same chemical structure, and a is an integer from 0 to 3;R3、R4It is each independently selected from singly-bound, alkylidene, replaces alkylene
Base;R5Indicate hydrogen or acetyl group;Work as R3When for singly-bound, R4It cannot be singly-bound;Work as R3When for methylene, R4It cannot be methylene;Institute
Straight chain, branch or cricoid saturated hydrocarbyl that term " alkyl " refers to 1~8 carbon atom are stated, the alkyl can be selected from methyl, second
One of base, propyl, isopropyl, butyl, isobutyl group, tert-butyl etc., straight chain, the branched alkyl of preferably 1~4 carbon atom;
The term " alkylidene " refers to the alkylidene of 1~3 carbon atom of straight chain, the alkylidene of preferably 1~2 carbon atom;The art
Language " substituted alkylene " refers to the alkylidene that at least one hydrogen atom is replaced by groups such as alkyl, alkoxy, aryl;It is described
Term " alkoxy " refers to the alkoxy of the straight chain of 1~6 carbon atom, branch;The term " aryl " refers to 6~15 carbon originals
The monocycle or polynary polycyclic aromatic hydrocarbon of son, the aromatic hydrocarbon of preferably 6~10 carbon atoms, the aromatic hydrocarbon are selected from phenyl or naphthyl,
Preferably phenyl;The term " heteroaryl " refers to the aromatic rings comprising 3~15 carbon and containing at least one N, O or S atom,
The aromatic rings can be selected from one of pyrrole radicals, pyridyl group, pyrimidine radicals, similar group etc.;The term " halogen " include fluorine,
One of chlorine, bromine, iodine etc..
The chemical general formula of a kind of double sulfhydryl compounds may be expressed as:
The preparation methods of a kind of double sulfhydryl compounds the following steps are included:
Method (I): when sulfydryl is directly connected in aryl, using aryl, the heteroaryl compound replaced containing hydroxyl;The
One step, by its in n,N-Dimethylformamide with N, the thio formyl chloride of N- dimethylamino alkali effect under be condensed;Second
Step, in diphenyl ether, is heated to 200 DEG C of progress rearrangement reactions;Third step is hydrolyzed in ethylene glycol and water by potassium hydroxide;
4th step protects sulfydryl by acetic anhydride and alkali.The reaction route is schematically as follows:
Method (II): when carbon atom is connected with aryl when one, sulfydryl interval, using alkyl-substituted aryl, heteraryl
Close object, and at least one hydrogen atom on the carbon atom that is connected with aryl of the alkyl;The first step passes through bromo in carbon tetrachloride
Succimide and benzoyl peroxide carry out benzyl position free radical bromo-reaction;Second step is replaced by thioacetic acid potassium
Reaction.The reaction route is schematically as follows:
Method (III): when carbon atom is connected with aryl when two, sulfydryl interval, using alkyl-substituted aryl, heteroaryl
Compound, and at least one hydrogen atom on the carbon atom that is connected with aryl of the alkyl;The first step passes through in carbon tetrachloride
NBS and benzoyl peroxide carry out benzyl position free radical bromo-reaction;Second step obtains triphenyl phosphorus by reacting with triphenyl phosphorus
Salt occurs Wei Tixi (wittig) with the compound containing aldehydes or ketones later and reacts.Third step, by drawing with thioacetic acid in light
It sends out progress addition reaction under the catalysis and action of ultraviolet radiation of agent or progress addition is anti-under heating by azodiisobutyronitrile catalysis
It answers.The reaction route is schematically as follows:
Method (IV): when two, sulfydryl interval, carbon atom is connected with aryl, the aryl, the heteraryl that are replaced using halogen
Close object;The first step, by carrying out Suzuki coupling reaction under alkali, the effect of four triphenyl phosphorus palladiums with ene boric acid;Second step passes through
Addition reaction is carried out under the catalysis and action of ultraviolet radiation of photoinitiator with thioacetic acid or is existed by azodiisobutyronitrile catalysis
Heating is lower to carry out addition reaction.The reaction route is schematically as follows:
The sulfhydryl protected base used in method (I), method (II), method (III) and method (IV) is acetyl group, can
Leniently removed at room temperature by alkali, wherein alkali is one in sodium hydroxide, potassium hydroxide, sodium ethoxide, sodium methoxide etc.
Kind;Solvent is one of water, ethyl alcohol, methanol, acetonitrile, tetrahydrofuran etc..Due to sulfydryl with acetyl group protect so that into
When the subsequent synthesis of row, sulfhydryl oxidase will not be led to the problem of and form by-product or sulfydryl the smell is awful.
In the first step of method (II) and method (III), bromo-succinimide and former with each carbon that can react
Sub- site inventory molar ratio is that (1~2.5) ︰ 1, benzoyl peroxide rub with the carbon atom site inventory that can each react
You are than for (0.05~0.2) ︰ 1, reaction temperature are 60~80 DEG C, and the reaction time is 2~12h.
In the second step of method (II), thioacetic acid potassium and with each bromine atom site inventory mole that can be reacted
Than for (1~2.5) ︰ 1, reaction temperature be 20~60 DEG C, the reaction time be 2~for 24 hours.The solvent is acetone, acetonitrile, N, N- bis-
One of methylformamide, tetrahydrofuran, 1,4- dioxane, methanol, ethyl alcohol etc..
In the second step of method (III), triphenylphosphine and with each bromine atom inventory molar ratio that can be reacted it is
(1.2~2.5) ︰ 1, reaction temperature are 50~80 DEG C, and the reaction time is 8~12h.Compound containing aldehydes or ketones and each can
The inventory molar ratio in the triphenylphosphine hydrobromate site of reaction is 1.2~2 ︰ 1, alkali and and the triphenyl that can each react
The inventory molar ratio in phosphine hydrobromate site is that (1.2~2) ︰ 1, reaction time are 1~8h.Solvent is water, methylene chloride, four
Hydrogen furans etc.;Alkali is one of sodium hydroxide, sodium ethoxide, sodium methoxide, potassium tert-butoxide etc..
In the third step of method (III) and the second step of method (IV), thioacetic acid and the alkene that can each react
The inventory molar ratio in site is that (the inventory molar ratio in 2~8) ︰ 1, photoinitiator and the alkene site that can each react is
(0.1~0.5) ︰ 1, reaction time are 12~48h.Solvent is one of tetrahydrofuran, 1,4- dioxane, acetonitrile etc.;Light
Initiator is one of dimethoxybenzoin, styrax, diethoxy acetophenone etc.;The ultraviolet light light wave a length of 254 used
~365nm.
In the third step of method (III) and the second step of method (IV), thioacetic acid and the alkene that can each react
The inventory molar ratio in site is (2~8) ︰ 1, the inventory mole of azodiisobutyronitrile and the alkene site that can each react
Than for (0.1~0.5) ︰ 1, reaction temperature are 60~80 DEG C, and the reaction time is 12~48h.Solvent is tetrahydrofuran, 1,4- dioxy
One of six rings, carbon tetrachloride, benzene etc..
In the first step of method (IV), the inventory molar ratio in ene boric acid and the halogen site that can each react is
(the inventory molar ratio in 1~2) ︰ 1, alkali and the halogen site that can each react is (2~6) ︰ 1, four triphenyl phosphorus palladiums and every
The inventory molar ratio in a halogen site that can be reacted is that (0.1~0.5) ︰ 1, reaction temperature are 80~120 DEG C, the reaction time
For 6~for 24 hours.Solvent is one of n,N-Dimethylformamide, Isosorbide-5-Nitrae-dioxane, water, toluene etc.;Alkali is sodium carbonate, carbon
Sour potassium, it is a kind of in potassium phosphate etc..
In one of method (I), method (II), method (III) and method (IV), corresponding raw material, Ke Yihe are used
The equal double thiol molecules of carbon atom number at interval, such as application method (III) can synthesize bis- (2- mercapto ethyl) the benzene first of 3,5-
Acid;Application method (IV) can synthesize bis- (2- mercapto the propyl)-benzoic acid of 3,5-.
Combination in method (I), method (II), method (III) and method (IV), uses corresponding raw material, Ke Yihe
The unequal double thiol molecules of carbon atom number at interval, such as application method (III) and method (II) combine and 3- (2- can be obtained
(acetyl mercapto) ethyl) -5- (2- (acetyl mercapto) methyl) benzoic acid and 3- (2- mercapto ethyl) -5- (thiopurine methyltransferase) benzoic acid.
The chemical general formula of the reduction chemical linkers of the response type containing double disulfide bond are as follows:
Wherein M1And M2It is the compound containing double sulfydryls, forms double disulfide bond by respective double sulfydryls, constitute the dimerization bodily form
Formula, S are sulphur atom;M1Selected from one of double sulfhydryl compounds, carboxyl diphenyl disulfide phenol, bis- (thiopurine methyltransferase) benzoic acid of 3,5- etc.;M2
Selected from double sulfhydryl compounds, lipoic acid, 2,3- dimercaprol dimercaptopropanol, 2,3- dimercapto propionic acid, 1,2- dimercapto propylamine, carboxyl benzene two
It is bis- (thiopurine methyltransferase) benzoic acid of thiophenol, 3,5-, residual by 3-30 amino acid with Cys-Xaa-Cys, Cys-Xaa-Xaa-Cys sequence
One of polypeptide of base composition etc.;Work as M1When for carboxyl diphenyl disulfide phenol, M2It cannot be carboxyl diphenyl disulfide phenol;It is residual in the polypeptide
Base Xaa be selected from amino acids Glycine (Gly, G), alanine (Ala, a), valine (Val, V), leucine (Leu, L), different bright ammonia
Acid (Ile, I), phenylalanine (Phe, P), tryptophan (Trp, W), tyrosine (Tyr, Y), aspartic acid (Asp, D), asparagus fern acyl
Amine (Asn, N), glutamic acid (Glu, E), lysine (Lys, K), glutamine (Gln, Q), methionine (Met, M), serine
It is a kind of in (Ser, S), threonine (Thr, T), proline (Pro, P), histidine (His, H), arginine (Arg, R) etc..
The chemical linkers of the reduction response type containing double disulfide bond can be M1And M2Represent double sulfhydryl compounds, M1
Represent double sulfhydryl compounds and M2Represent the polypeptide.
The preparation method of the reduction chemical linkers of the response type containing double disulfide bond, is original with the compound containing double sulfydryls
Material is prepared by the method for the activation of two sulphur, two pyridine or dimethylsulfoxide oxidation, and the solvent that dimethylsulfoxide oxidation uses is dimethyl
The volume ratio of sulfoxide and 7.4 phosphate buffer mixed solution of pH, the dimethyl sulfoxide and 7.4 phosphate buffer of pH is 20 ︰
80, oxidation sulfhydryl compound molar concentration control is about 1mM;Two sulphur, two pyridine and the Sulfhydryl Groups inventory that can each react
Molar ratio is that (1~10) ︰ 1, the solvent that two sulphur, two pyridine uses are methanol, ethyl alcohol, acetonitrile, water, dimethyl sulfoxide, N, N- diformazan
One of base formamide etc..
Beneficial effects of the present invention:
(1) a kind of double sulfhydryl compounds are compared to common double sulfhydryl compounds with can be with the reactive official of functionalization
It can roll into a ball, for building there is multi-functional biomaterial to provide basis.The preparation method is simple, low in cost, is easy to industry
Change.Further, it is also possible to easily synthesize different substituted double thiol molecules.Synthesized thiol molecule is protected with acetyl group,
Side reaction when subsequent reactions can be reduced.
(2) a kind of double sulfhydryl compounds are by preferably, will not or be hardly formed intramolecular disulfide bond, main composition point
Disulfide bond between son forms more disulfide bond macrocycle molecules, primarily forms double disulfide bond molecules.Using described containing double disulfide bond
The preparation method of chemical linkers can obtain product with high productivity, reduce by-product common in more sulfhydryl compound reactions.
(3) a kind of chemical linkers containing double disulfide bond, since it forms based on sulfydryl the reaction of disulfide bond,
A series of attachments with different reduction response properties can simply be synthesized.In addition, constituting described one kind of the attachment
Double sulfhydryl compounds, the carbon atom being connected with sulfydryl can have different substituent groups by the preparation method, so that
Chemical environment around sulfydryl is different, also will affect the rate of fracture.It is available to adapt to different biographies by the two methods
The attachment of sense and delivering release demand.In addition, such attachment small volume, good water solubility, so that its shadow to load
Sound further decreases.
(4) fluorescence probe is constructed using a kind of chemical linkers containing double disulfide bond, which has good
Stability, lower side effect, can be efficiently applied to the sensing of bioluminescence imaging and bioreductive environment.
Detailed description of the invention
Fig. 1 is that the release dynamics of 1mM and 10mM GSH of the preferred double disulfide bond attachments in simulation physiological condition are bent
Line;
Fig. 2 is cell imaging figure (the fluorescence probe concentration that synthesized double disulfide bond attachments are applied to bio-sensing
2uM), light field, fluorescence superimposed image (a), fluorescent image (b);
Fig. 3 is cell imaging figure (the fluorescence probe concentration that synthesized double disulfide bond attachments are applied to bio-sensing
5uM), light field, fluorescence superimposed image (a), fluorescent image (b);
Fig. 4 is the fluorescence spectrum that 10mM GSH restores fluorescence probe F2.
Specific embodiment
The compound of the present invention and method will further be shown by the following example.
In-vitro simulated release experiment is carried out to following preferred chemical linkers and its single disulfide bond object of reference:
When simulating blood circulation, single disulfide bond attachment all quick release in 1mM and 10mM, release half-life period and
GSH concentration is in a linear relationship.Unlike, under conditions of 1mM GSH, double disulfide bond attachments only occur seldom when 720min
Release;And when simulation intracellular environment, under conditions of 10mM GSH, when 240min, double disulfide bond attachments almost discharged.
These results suggest that such double disulfide bond attachment has good nonlinear reduction response property.
Shown in the principle of this nonlinear response: first, traditional single disulfide bond feelings existing for thiol molecule reducing agent
Under condition, a step sulfydryl-disulfide bond exchange reaction can occur, directly so as to cause disulfide bonds.It is constant in reductant concentration
In the case of, the fracture of disulfide bond follows first-order kinetics, service life (τ1/2) in a linear relationship with the concentration of reducing agent.Its
Two, the redox fracture process of double disulfide bond is different from single disulfide bond, in the lower situation of reductant concentration, generating unit
Double disulfide bond (i.e. one of disulfide bond is broken) intermediate that disjunction is split due to the synergisticing stable effect between double disulfide bond,
Sulfydryl-disulfide bond exchange reaction of intramolecular can occur, to re-form double disulfide bond;But it is higher in reductant concentration
In the case where, double disulfide bond that portion fractures occur further can occur sulfydryl-disulfide bond with the reducing agent in environment and exchange instead
It answers, is broken in succession so as to cause two disulfide bond.Therefore, double disulfide bond are steady with superelevation under conditions of week reduction
It is qualitative, and it is then similar with single disulfide bond under conditions of strong reducing property, it can occur quickly to be broken.Proposed by the present invention double two
Sulfide linkage is as follows:
In certain embodiments of the present invention, the fluorescence probe with flowering structure has been synthesized:
And cell imaging experiment, result and the extracorporeal releasing experiment result phase of cell imaging have been carried out using fluorescence probe F2
Meet, such double disulfide bond attachment has non-linear reduction responsiveness.
Specific embodiment is given below.
Embodiment 1
The preparation of bis- (the 2- mercapto ethyl) benzoic acid (1) of 3,5-:
The synthetic route of bis- (the 2- mercapto ethyl) benzoic acid (1) of 3,5- is as follows:
The synthesis of 3,5- divinyl benzoic acid (1d).(1) 3,5- mesitylenic acid (1a) (1.0g, 6.6mmol) is molten
In 10mL carbon tetrachloride, the dibenzoyl peroxide of N-bromosuccinimide (2.37g, 13.3mmol) and catalytic amount is added
(73mg).It is heated to reflux 3h, cold filtration collects filtrate.Vacuum rotation goes filtrate to obtain bis- (bromomethyl) benzene of white solid 3,5-
Formic acid (1b).(2) above-mentioned product (1b) is dissolved in 25mL acetone.It is slowly added to triphenylphosphine (3.49g, 13.3mmol) and flows back
Overnight.It is cooling, white solid is collected by filtration, and wash with hexane and ether, obtains intermediate (1c).(3) it is added to salt (3c)
30mL formalin (37% formalin of 240mmol, 20mL, 10mL water).5N hydroxide is slowly dropped into the mixture
Sodium water solution (7.5mL, 37.5mmol).Solution is gradually clarified, and generates white precipitate later.React at room temperature 3h.It is heavy to filter out white
It forms sediment, pH=2 is neutralized to concentrated hydrochloric acid later.Solid is precipitated, filters and be dried to obtain white solid 0.31g, yield 26.5%.1H
NMR(500MHz,CDCl3) δ 8.07 (d, J=1.6Hz, 2H), 7.67 (d, J=1.8Hz, 1H), 6.79 (dd, J=17.5,
10.9Hz, 2H), 5.92-5.85 (m, 2H), 5.39 (d, J=10.9Hz, 2H)13C NMR(125MHz,CDCl3)δ138.30,
135.70,129.95,129.03,127.09,115.57.
Bis- (2- (the synthesis of acetyl mercapto (ethyl) benzoic acid (1e) of 3,5-.3d (50mg, 0.29mmol), thioacetic acid
(0.42mL, 5.96mmol) and catalytic amount dimethoxybenzoin (5mg) are dissolved in 3mL tetrahydrofuran.Solution is in 365nm UV-
The lower reaction of light (8W) irradiation is for 24 hours.Solvent is removed in rotation, obtains white solid 29mg, yield 31% with column chromatography for separation.1H NMR
(400MHz,CDCl3) δ 7.85 (d, J=1.7Hz, 2H), 7.28 (s, 1H), 3.15 (dd, J=8.5,6.5Hz, 4H), 2.94
(dd, J=8.6,6.5Hz, 4H), 2.36 (s, 6H)13C NMR(100MHz,CDCl3)δ195.62,171.73,140.67,
135.70,134.44,129.75,129.49,128.59,126.27,77.36,77.24,77.04,76.72,35.49,
35.44,30.68,30.27,30.21,21.20.ESI MS(m/z):348.8[M+Na]+.
Bis- (2- (the synthesis of acetyl mercapto (ethyl) benzoic acid (1e) of 3,5-.3d (50mg, 0.29mmol), thioacetic acid
(0.42mL, 5.96mmol) and catalytic amount azodiisobutyronitrile (10mg) are dissolved in 10mL carbon tetrachloride, and flow back 6h, and cooling back spin is gone
Solvent, column chromatography for separation obtain white solid, yield 22%.
The synthesis of bis- (the 2- mercapto ethyl) benzoic acid (1) of 3,5-.3e (20mg, 0.06mmol) is dissolved in 1mL methanol, and 3N hydrogen is added
Sodium hydroxide solution (1mL), is stirred at room temperature 1h under nitrogen protection.1N hydrochloric acid is neutralized to pH=2.White solid is precipitated, with centrifugation
Separation, vacuum drying obtain white solid 14mg.1H NMR(500MHz,CDCl3) δ 7.83 (d, J=1.7Hz, 2H), 7.64 (d,
J=1.7Hz, 1H), 2.99~2.95 (m, 4H), 2.83~2.79 (m, 4H), 1.42~1.39 (m, 2H)
Embodiment 2
The preparation of bis- (the 2- mercapto ethyl) benzoic acid (2) of 2,5-:
The synthetic route of bis- (the 2- mercapto ethyl) benzoic acid (2) of 2,5- is as follows:
The synthesis of 2,5- divinyl benzoic acid (2d).(1) 2,5- mesitylenic acid (2a) (1.0g, 6.6mmol) is molten
The dibenzoyl peroxide of N-bromosuccinimide (2.37g, 13.3mmol) and catalytic amount is added in 10mL carbon tetrachloride
(73mg).It is heated to reflux 3h, filtrate is collected in cooling filtering.Vacuum rotation goes filtrate to obtain bis- (bromomethyl) benzene of white solid 2,5-
Formic acid (2b).(2) above-mentioned product (2b) is dissolved in 25mL acetone.It is slowly added to triphenylphosphine (3.49g, 13.3mmol) and flows back
Overnight.It is cooling, white solid is collected by filtration, and wash with hexane and ether, obtains intermediate (2c).(3) it is added to salt (4c)
30mL formalin (37% formalin of 240mmol, 20mL, 10mL water).5N hydroxide is slowly dropped into the mixture
Sodium water solution (7.5mL, 37.5mmol).Solution is gradually clarified, and generates white precipitate later.React at room temperature 3h.It is heavy to filter out white
It forms sediment, pH=2 is neutralized to concentrated hydrochloric acid later.Solid is precipitated, filters and be dried to obtain white solid 0.4020g, yield 35%.1H
NMR(500MHz,CDCl3) δ 8.08 (s, 1H), 7.62~7.60 (m, 2H), 7.60~7.55 (m, 1H), 6.76 (dd, J=
17.6,10.9Hz, 1H), 5.90~5.82 (m, 1H), 5.71 (dd, J=17.4,1.3Hz, 1H), 5.38 (ddd, J=22.3,
11.0,0.8Hz,2H).13C NMR(125MHz,CDCl3)δ171.93,139.54,136.94,135.48,132.13,
130.18,129.14,128.54,127.61,116.62,115.09。
The synthesis of bis- (2- (acetyl mercapto) ethyl) benzoic acid (2e) of 2,5-.2d (50mg, 0.29mmol), thioacetic acid
(0.42mL, 5.96mmol) and catalytic amount dimethoxybenzoin (5mg) are dissolved in 3mL tetrahydrofuran.Solution is in 365nm UV-
The lower reaction of light (8W) irradiation is for 24 hours.Solvent is removed in rotation, obtains white solid 21mg, yield 22% with column chromatography for separation.1H NMR
(500MHz,CDCl3) δ 7.92 (d, J=1.9Hz, 1H), 7.39 (dd, J=7.8,2.0Hz, 1H), 7.31 (d, J=7.8Hz,
1H), 3.27 (t, J=7.7Hz, 2H), 3.19~3.15 (m, 4H), 2.93 (t, J=8.0Hz, 2H), 2.36 (s, 3H), 2.35
(s,3H).13C NMR(125MHz,CDCl3)δ195.85,195.51,171.67,140.77,138.62,133.24,132.07,
131.84,128.28,35.13,34.21,30.64,30.61,30.22,30.17.ESI MS(m/z):348.8[M+Na]+。
The synthesis of bis- (the 2- mercapto ethyl) benzoic acid (2) of 2,5-.2e (20mg, 0.06mmol) is dissolved in 1mL methanol, and 3N hydrogen is added
Sodium hydroxide solution (1mL), is stirred at room temperature 1h under nitrogen protection.1N hydrochloric acid is neutralized to pH=2.White solid is precipitated, with centrifugation
Separation, vacuum drying obtain white solid 13mg.1H NMR(500MHz,CDCl3) δ 7.93 (d, J=2.0Hz, 1H), 7.38
(dd, J=7.8,2.1Hz, 1H), 7.30 (s, 1H), 3.34~3.30 (m, 2H), 2.99~2.96 (m, 2H), 2.86~2.81
(m, 4H), 1.45 (t, J=8.1Hz, 1H), 1.41 (t, J=7.9Hz, 1H).
Embodiment 3
The preparation of 3- (2- mercapto ethyl) -5- (thiopurine methyltransferase) benzoic acid (3):
The synthetic route of 3- (2- mercapto ethyl) -5- (thiopurine methyltransferase) benzoic acid (3) is as follows:
The synthesis of 3- methyl -5- vinyl benzoic acid (3d).(1) 3,5- mesitylenic acid (3a) (1.0g, 6.6mmol)
It is dissolved in the dibenzoyl peroxide that N-bromosuccinimide (1.18g, 6.7mmol) and catalytic amount is added in 10mL carbon tetrachloride
(37mg).It is heated to reflux 3h, filtrate is collected in cooling filtering.Vacuum rotation goes filtrate to obtain white solid.(2) by above-mentioned product
(5b) is dissolved in 25mL acetone.It is slowly added to triphenylphosphine (1.75g, 6.7mmol) and is refluxed overnight.It is cooling, white is collected by filtration
Solid, and washed with hexane and ether, obtain intermediate (3c).(3) to salt (3c) be added 20mL formalin (120mmol,
10mL37% formalin, 10mL water).To the mixture be slowly dropped into 5N sodium hydrate aqueous solution (3.75mL,
18.8mmol).Solution is gradually clarified, and generates white precipitate later.React at room temperature 3h.White precipitate is filtered out, later with concentrated hydrochloric acid
It is neutralized to pH=2.Solid is precipitated, filters and be dried to obtain white solid 0.4360g, yield 40.8%.1H NMR(500MHz,
CDCl3) δ 7.98 (s, 1H), 7.84 (s, 1H), 7.48 (s, 1H), 6.75 (dd, J=17.5,10.9Hz, 1H), 5.85 (d, J=
17.6Hz, 1H), 5.34 (d, J=10.9Hz, 1H), 2.44 (s, 3H)13C NMR(125MHz,CDCl3)δ170.99,
138.52,137.96,135.92,132.04,129.98,129.54,125.25,115.05,21.19.
The synthesis of 3- (2- (acetyl mercapto) ethyl)-methyl benzoic acid (3e).3d (150mg, 0.92mmol), thioacetic acid
(0.50mL, 7.3mmol) and catalytic amount dimethoxybenzoin (30mg) are dissolved in 3mL tetrahydrofuran.Solution is in 365nm UV-
The lower reaction of light (8W) irradiation is for 24 hours.Solvent is removed in rotation, obtains white solid 75.9mg, yield 34.7% with column chromatography for separation.1H
NMR(500MHz,CDCl3) δ 7.80 (s, 1H), 7.76 (s, 1H), 7.29 (s, 1H), 3.18~3.10 (m, 2H), 2.92~
2.87(m,2H),2.40(s,3H),2.34(s,3H).13C NMR(125MHz,CDCl3)δ195.64,172.07,140.31,
138.57,134.92,129.05,128.26,127.44,35.45,30.66,30.27,21.19。
The synthesis of 3- (2- (acetyl mercapto) ethyl) -5- (bromomethyl) benzoic acid (3f).3e (70mg, 0.29mmol) is dissolved in
N-bromosuccinimide (56mg, 0.32mmol), catalytic amount dibenzoyl peroxide is added in 10mL carbon tetrachloride.It heats back
3h is flowed, cold filtration is spin-dried for filtrate.It is recrystallized with ethyl acetate and hexane, obtains white solid 81mg, yield 89.1%.1H
NMR(500MHz,CDCl3) δ 7.98 (s, 1H), 7.86 (s, 1H), 7.39 (s, 1H), 4.51 (s, 2H), 3.22~3.12 (m,
2H), 2.90~2.85 (m, 2H), 2.33 (s, 3H).
The synthesis of 3- (2- (acetyl mercapto) ethyl) -5- (2- (acetyl mercapto) methyl) benzoic acid (3g).3f(81mg,
It 0.26mmol) is dissolved in 10mL acetone, thioacetic acid potassium (58mg, 0.52mmol) is added, 3h is stirred at room temperature.Be added ethyl acetate and
Water stratification, with ethyl acetate extraction 3 times, solvent is removed in rotation, is recrystallized with ethyl acetate and hexane, obtains white solid 77mg, produces
Rate 95.0%.1H NMR(500MHz,CDCl3)δ7.82(s,1H),7.78(s,1H),7.35(s,1H),3.87(s,2H),3.12
~2.80 (m, 4H), 2.33 (m, 6H).
The synthesis of 3- (2- mercapto ethyl) -5- (thiopurine methyltransferase) benzoic acid (3).3g (20mg, 0.06mmol) is dissolved in 1mL methanol,
It is added 3N sodium hydroxide solution (1mL), 1h is stirred at room temperature under nitrogen protection.1N hydrochloric acid is neutralized to pH=2.White solid analysis
Out, with centrifuge separation, vacuum drying obtains white solid 12.1mg.1H NMR(500MHz,CDCl3)δ7.80(s,1H),7.76
(s, 1H), 7.30 (s, 1H), 3.80 (s, 2H), 2.95~2.81 (m, 4H), 2.30 (s, 1H), 1.40 (s, 1H)
Embodiment 4
The preparation of bis- (2- mercapto the propyl)-benzoic acid of 3,5-:
The synthetic route of bis- (2- mercapto the propyl)-benzoic acid of 3,5- is as follows:
The synthesis of bis- (the acrylic)-benzoic acid (4b) of 3,5-.Under nitrogen atmosphere, 4a (280mg, 1mmol) is dissolved in 6mL N,
Dinethylformamide is added four triphenyl phosphorus palladiums (230mg, 0.2mmol), is stirred at room temperature 10min, be added sodium carbonate (1.1g,
10.5mmol), 4mL water and 1- propylene -1- boric acid (179mg, 2.1mmol), flow back 12h.After cooling, 30mL water, 1N salt is added
Acid is neutralized to pH=2, obtains gray precipitate, filtering.Column chromatography for separation white solid 145.4mg, yield 72%.
The synthesis of bis- (2- mercapto the propyl)-benzoic acid (4) of 3,5-.4b (100mg, 0.5mmol), thioacetic acid (0.27mL,
4mmol) and catalytic amount dimethoxybenzoin (30mg) is dissolved in 3mL acetonitrile.Solution is anti-under 365nm UV-light (8W) irradiation
It should for 24 hours.Rotary Evaporators concentration, with column chromatography for separation.It is dissolved in 1mL methanol later, is added 3N sodium hydroxide solution (1mL), in
1h is stirred at room temperature under nitrogen protection.1N hydrochloric acid is neutralized to pH=2.White solid is precipitated, and with centrifuge separation, vacuum drying obtains white
Color solid 24.2mg, yield 17.9%.1H NMR(500MHz,CDCl3) δ 7.85 (d, J=1.6Hz, 2H), 7.62 (d, J=
1.6Hz, 1H), 3.01~2.72 (m, 6H), 1.47 (d, 6H), 1.41~1.38 (m, 2H) .ESI MS (m/z): 268.9 [M-
H]-。
Embodiment 5
The preparation of double disulfide bond attachments of carboxyl diphenyl disulfide phenol and bis- (thiopurine methyltransferase) the benzoic acid compositions of 3,5-:
The synthesized reference of carboxyl diphenyl disulfide phenol and bis- (thiopurine methyltransferase) benzoic acid of 3,5- from West, K.R., et al.,
Organic Letters7.13(2005):2615-8.By carboxyl diphenyl disulfide phenol (3.7mg, 0.02mmol) and bis- (the mercapto first of 3,5-
Base) benzoic acid (4.2mg, 0.02mmol) is dissolved in (20 ︰ in 5mL dimethyl sulfoxide and 7.4 phosphate buffer mixed solution of pH
80), sulfhydryl compound concentration control is about 1mM.Room temperature reaction 2 days uses preparation after Rotary Evaporators concentration after reaction
Chromatographic isolation obtains 5.1mg product, yield about 65%.ESI MS(m/z):395.0[M-H]-。
Embodiment 6
The preparation of double disulfide bond attachments of bis- (thiopurine methyltransferase) the benzoic acid compositions of 3,5-:
2,2'-, bis- sulphur, two pyridine (220mg, 1mmol) is dissolved in 20mL methanol.By bis- (thiopurine methyltransferase) benzoic acid of 3,5-
(20mg, 0.09mmol) is dissolved in 5mL methanol, and is instilled in the methanol solution of two sulphur, two pyridine, is reacted at room temperature 8h, is rotated later
Evaporimeter concentration, prepares chromatographic isolation.The intermediate that preparation chromatographic isolation obtains is dissolved in 5mL methanol, and the 3,5- of equivalent are added
Bis- (thiopurine methyltransferase) benzoic acid react at room temperature 1h, prepare chromatogram purification after concentration, obtain product 32.2mg, yield about 81%.ESI
MS(m/z):422.3[M-H]-。
Embodiment 7
The preparation of double disulfide bond attachments of bis- (2- mercapto ethyl) the benzoic acid compositions of 3,5-:
Bis- (the 2- mercapto ethyl) benzoic acid (4.8mg, 0.02mmol) of 3,5- are dissolved in 5mL dimethyl sulfoxide and 7.4 phosphoric acid of pH is slow
In fliud flushing mixed solution (20 ︰ 80), the control of sulfhydryl compound concentration is about 1mM.Room temperature reaction 2 days, after reaction, rotation are steamed
Preparation chromatographic isolation is used after sending out instrument concentration, obtains 3.8mg product, yield about 79%.ESI MS(m/z):479.0[M-H]-。
Embodiment 8
The preparation of double disulfide bond attachments of bis- (2- mercapto ethyl) the benzoic acid compositions of 3,5-:
2,2'-, bis- sulphur, two pyridine (220mg, 1mmol) is dissolved in 20mL methanol.By bis- (the 2- mercapto ethyl) benzoic acid of 3,5-
(24mg, 0.1mmol) is dissolved in 5mL methanol, and is instilled in the methanol solution of two sulphur, two pyridine, is reacted at room temperature 8h, is rotated later
Evaporimeter concentration, prepares chromatographic isolation.The intermediate that preparation chromatographic isolation obtains is dissolved in 5mL methanol, and the 3,5- of equivalent are added
Bis- (2- mercapto ethyl) benzoic acid react at room temperature 1h, prepare chromatogram purification after concentration, obtain product 41.7mg, yield about 87%.
ESI MS(m/z):479.0[M-H]-。
Embodiment 9
The preparation of reduction response type fluorescence probe based on double disulfide bond attachments:
3,5- bis- (2- mercapto ethyl) benzoic acid (9a) (3.26mg, 13.5umol), are dissolved in 2mL n,N-Dimethylformamide
In, 2- (7- azo benzotriazole)-N, N, N', N'- tetramethylurea hexafluorophosphoric acid ester (20mg, 52.6umol), N, N- is added
Diisopropylethylamine (13mg, 100umol).1h is reacted at room temperature, 4,7,10- tri- oxygen -1,13- tridecane diamines are added dropwise later
(22mg, 100umol) reacts at room temperature 4h, and three (2- carboxyethyl) phosphines are added later and restore 30min.It is concentrated, prepare chromatographically pure
Change, white solid (9b) 2.2mg, yield 36% are obtained after freeze-drying.
Intermediate (9b) (2.2mg, 4.9umol) is dissolved in the phosphate buffer of 1mLpH7.4, and be quickly adding into containing
In the phosphate buffer of the 1mL pH7.4 of bis- sulphur of 2,2'-, two pyridine (22mg, 98umol).Reaction 3h is stirred at room temperature, later with height
Effect liquid phase chromatogram purifying, obtains white solid (9c) 2.3mg, yield 70% after freeze-drying.
Intermediate (9c) and fluoro fluorescein N-hydroxy-succinamide ester are dissolved in anhydrous dimethyl sulphoxide respectively, with for
2mM solution.100 μ L solution are respectively taken, with the mixing of 1 ︰, 1 ratio, and a small amount of n,N-diisopropylethylamine is added and adjusts pH to 8~9, room
Warm shaking table reaction 8h obtains yellow solid (9d), is dissolved in anhydrous dimethyl sulphoxide later with high-efficient liquid phase chromatogram purification after freeze-drying
In, and, yield 91% quantitative with ultraviolet-visible absorption spectroscopy.
3,5- bis- (2- mercapto ethyl) benzoic acid (9a) (30mg, 0.14mmol), are dissolved in 1mL n,N-Dimethylformamide, add
Enter RRRRRK-Dabcyl (52.9mg, 0.045mmol), 2- (7- azo benzotriazole)-N, N, N', N'- tetramethylurea hexafluoro
Phosphate (38.5mg, 0.1mmol) and n,N-diisopropylethylamine (35mg, 0.27mmol) react at room temperature 12h.Later plus
Enter three (2- carboxyethyl) phosphines reduction 30min.Chromatogram purification is prepared, orange solids (9e) 51.2mg, yield 82% are obtained after freeze-drying.
Intermediate (9d) and intermediate (9e) are dissolved in anhydrous dimethyl sulphoxide respectively, matching is 2mM solution.Respectively take 100 μ
L solution is put by 1 ︰, 1 equivalent in the phosphate buffer solution of 2mL pH7.4, reacts 30min, and high-efficient liquid phase chromatogram purification is simultaneously lyophilized
Fluorescence probe (F1) is obtained, is dissolved in anhydrous dimethyl sulphoxide, and is quantitative with ultraviolet-visible absorption spectroscopy, yield 91%.
MALDI-TOF(m/z):2236.2[M+H]+。
Embodiment 10
The preparation of reduction response type fluorescence probe based on double disulfide bond attachments:
Using the similar approach in embodiment 9, intermediate (10d) is obtained by raw material of ethylenediamine.By itself and polypeptide A c-
WGCGGCGRKKRRQRRR-NH2It is dissolved in anhydrous dimethyl sulphoxide respectively, matching is 2mM solution.100 μ L solution are respectively taken, by 1 ︰ 1
Equivalent is put into the phosphate buffer solution of 2mL pH7.4, reacts 30min, and high-efficient liquid phase chromatogram purification and freeze-drying obtain fluorescence spy
Needle (F2), is dissolved in anhydrous dimethyl sulphoxide, and quantitative with ultraviolet-visible absorption spectroscopy, yield 92%.MALDI-TOF MS(m/
z):2674.4[M-H]-。
Embodiment 11
In-vitro simulated release experiment:
Double two sulphur attachments and traditional single disulfide bond in the present invention are in glutathione (GSH) solution of various concentration
Reduction discharge comparison, environment when blood circulation, ring when 10mM GSH discharges into the cell are simulated with 1mM GSH in test
Border.Compound for release experiment is as follows.Wherein, used single disulfide bond attachment on corresponding monomer by shielding
Or it after reducing sulfydryl, is obtained using oxidation.
Solution used, which is placed in the round-bottomed flask with rubber stopper before use, is bubbled deoxygenation with nitrogen.In order to avoid
The influence of oxygen, all processes carry out in anaerobic culture box.Detailed process is as follows: take 0.2mL phosphate buffer (100mM,
PH7.4) in the low protein adsorption centrifuge tube of 1.5mL, being separately added into bis-/mono- disulfide bond compound solutions of 50 μ L, (ultimate density is
5uM) and the glutathione solution of 0.25mL various concentration.At regular intervals, take 40 μ L reaction solutions rapid in empty centrifuge tube
It is quenched and is reacted with liquid nitrogen frozen.After to be sampled, each sample is subjected to high performance liquid chromatography (HPLC) and analyzes (sampling volume
30 μ L) it is quantitative, it draws kinetic curve fittings and calculates half-life period.Different single, double disulfide bond attachments are at 1mM and 10mM GSH
Release half-life period result referring to table 1, it is providing statistics indicate that double disulfide bond attachments are compared to the single disulfide bond attachment of tradition, tool
There is controllable non-linear reduction responsiveness, can be used as the attachment in prodrug, can reach and hardly be discharged in blood circulation,
And enter the effectiveness of quick release after target site.For different double disulfide bond attachments, such as D2 and D4, with different
Responsiveness is restored, solves the demand discharged under different reducing conditions.Wherein, the release of preferred double disulfide bond attachment D4
Kinetic curve is shown in Fig. 1.
Table 1
Note*: half-life period is extremely short, and the sampling time has influenced last result.
Note**: half-life period is extremely long, and 720min is only broken 7%, can not be fitted.
Note***: referring to Zhai, LX, et al.Chem.Eur.J., 20.52 (2014): 17507-14.
Embodiment 12
The cell imaging experiment of fluorescence probe F2 uses Hela cell in embodiment 10, in 37 DEG C, 5%CO2Under ring
In border, cultivated in the DMEM culture medium of serum-free.Before experiment, cell inoculation is in culture plate, every hole concentration 105It is a, upper
After being incubated for for 24 hours under the conditions of stating, remove matrix, and cleaned with PBS.The fluorescence probe F2 of respective concentration is added, and is incubated for corresponding
Time.Later, it is imaged using fluorescence microscope and carries out cell imaging experiment (488nm laser excitation), experimental result is shown in Fig. 2 and figures
3。
Polypeptide in fluorescence probe F2 has fluorescent quenching effect to fluorophor fluoro fluorescein, when double disulfide bond connect
When object is broken, polypeptide is separated with fluorophor, and fluorescence can restore.From the result of cell imaging as it can be seen that when being incubated for 4h,
Fluorescence in the imaging of the probe of 2uM or 5uM concentration is all weaker, illustrates that fraction fracture does not occur or only occurs for probe.When
When being incubated for for 24 hours, the fluorescence in the imaging of the probe of 2uM or 5uM concentration is significantly increased, and illustrates that probe is largely resolved
It splits, so that fluorescence restores.The result of fluorescence imaging is consistent with the result of in-vitro simulated release, such double disulfide bond connection
Object has non-linear reduction responsiveness.
Fig. 4 provides the fluorescence spectrum of 10mM GSH reduction fluorescence probe F2.
Claims (5)
1. restoring chemical linkers of the response type containing double disulfide bond, it is characterised in that its chemical general formula are as follows:
It is by the compound SH-M containing double sulfydryls1- SH and SH-M2Double disulfide bond connection that-SH is formed by respective double sulfydryls
The dimer constituted;Wherein SH is sulfydryl, and S is sulphur atom, M1And M2It is the residues Structures for removing thiol portion;
SH-M1- SH is selected from double sulfhydryl compounds with following chemical general formula:
SH-M2- SH is selected from double sulfhydryl compounds with following chemical general formula:
2,3- dimercaprol dimercaptopropanol, 1,2- dimercapto propylamine, has Cys-Xaa-Cys or Cys-Xaa- at 2,3- dimercapto propionic acid
One of the polypeptide of Xaa-Cys sequence being made of 3-30 amino acid residue;
Ar indicates phenyl in the above chemical general formula;R1Indicate singly-bound;Y indicates carboxyl, amino, hydroxyl, azido, sulfonic group;R2Table
Show hydrogen, and a is 3;R3、R4It is each independently selected from the alkylidene of singly-bound, 1~3 carbon atom;R5Indicate hydrogen;
Work as SH-M1When-SH is carboxyl diphenyl disulfide phenol, SH-M2- SH cannot be carboxyl diphenyl disulfide phenol;Residue Xaa is selected in the polypeptide
From amino acids Glycine (Gly, G), alanine (Ala, a), valine (Val, V), leucine (Leu, L), isoleucine (Ile,
I), phenylalanine (Phe, P), tryptophan (Trp, W), tyrosine (Tyr, Y), aspartic acid (Asp, D), asparagine (Asn,
N), glutamic acid (Glu, E), lysine (Lys, K), glutamine (Gln, Q), methionine (Met, M), serine (Ser, S),
It is threonine (Thr, T), proline (Pro, P), histidine (His, H), a kind of in arginine (Arg, R).
2. reduction chemical linkers of the response type containing double disulfide bond as described in claim 1, it is characterised in that form dimer
Double sulfhydryl compound SH-M1- SH and SH-M2- SH chemical general formula are as follows:
3. reduction chemical linkers of the response type containing double disulfide bond as described in claim 1, it is characterised in that the reduction response
The preparation method of chemical linkers of the type containing double disulfide bond, it is living by two sulphur, two pyridine using the compound containing double sulfydryls as raw material
Change or the preparation of the method for dimethylsulfoxide oxidation, the solvent that dimethylsulfoxide oxidation uses are dimethyl sulfoxide and 7.4 phosphoric acid buffer of pH
The volume ratio of liquid mixed solution, the dimethyl sulfoxide and 7.4 phosphate buffer of pH is 20 ︰ 80, aoxidizes sulfhydryl compound mole
Concentration control is 1mM;Two sulphur, two pyridine is (1~10) ︰ 1, two sulphur with the Sulfhydryl Groups inventory molar ratio that can each react
The solvent that two pyridines use is one of methanol, ethyl alcohol, acetonitrile, water, dimethyl sulfoxide, n,N-Dimethylformamide.
4. a kind of method based on synergistic effect regulation disulfide bond redox responsiveness between key, the method includes providing as weighed
Benefit require 1 described in one kind reduction chemical linkers and preparation method thereof of the response type containing double disulfide bond, the method is by containing double
The compound SH-M of sulfydryl1- SH and SH-M2Double disulfide bond that-SH is formed by respective double sulfydryls.
5. as described in claim 1 reduction chemical linkers of the response type containing double disulfide bond synthesis have controlled drug delivering,
The purposes of the molecule of release and bio-sensing function.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710756890.2A CN107501142B (en) | 2017-08-29 | 2017-08-29 | Restore chemical linkers and its preparation and purposes of the response type containing double disulfide bond |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710756890.2A CN107501142B (en) | 2017-08-29 | 2017-08-29 | Restore chemical linkers and its preparation and purposes of the response type containing double disulfide bond |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107501142A CN107501142A (en) | 2017-12-22 |
CN107501142B true CN107501142B (en) | 2019-11-08 |
Family
ID=60693212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710756890.2A Active CN107501142B (en) | 2017-08-29 | 2017-08-29 | Restore chemical linkers and its preparation and purposes of the response type containing double disulfide bond |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107501142B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116444407A (en) * | 2023-04-28 | 2023-07-18 | 南通大学 | Compound containing clustered disulfide bond unit and synthesis method and application thereof |
CN116754760B (en) * | 2023-06-14 | 2024-01-26 | 之江实验室 | Method for coupling 2, 4-Dinitrophenol (DNP) with controlled cleavage of antibody |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078180A2 (en) * | 2003-03-03 | 2004-09-16 | Guilford Pharmaceuticals Inc. | Naaladase inhibitors for treating opioid tolerance |
CN104277000A (en) * | 2014-10-29 | 2015-01-14 | 上海绿盎生物科技有限公司 | Abscisic acid receptor stimulant raw drug and preparation method thereof |
CN106366160A (en) * | 2016-10-11 | 2017-02-01 | 厦门大学 | Method for establishing polypeptide molecular skeleton rich in disulfide bond based on disulfide bond precise pairing |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571405A (en) * | 1984-05-29 | 1986-02-18 | Miles Laboratories, Inc. | Anti-allergic chromone- or thiochromone-5-oxamic acid derivatives, compositions, and method of use therefor |
-
2017
- 2017-08-29 CN CN201710756890.2A patent/CN107501142B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078180A2 (en) * | 2003-03-03 | 2004-09-16 | Guilford Pharmaceuticals Inc. | Naaladase inhibitors for treating opioid tolerance |
CN104277000A (en) * | 2014-10-29 | 2015-01-14 | 上海绿盎生物科技有限公司 | Abscisic acid receptor stimulant raw drug and preparation method thereof |
CN106366160A (en) * | 2016-10-11 | 2017-02-01 | 厦门大学 | Method for establishing polypeptide molecular skeleton rich in disulfide bond based on disulfide bond precise pairing |
Non-Patent Citations (4)
Title |
---|
Selection and Amplification of HostsFrom Dynamic Combinatorial Libraries of Macrocyclic Disulfides;Sijbren Otto等;《SCIENCE》;20070726;第591页 * |
stereoselective Sulfur Extrusion Reactionof syn-and anti-l0,20-Dibromo-2,3,12,13-Tetrathia[4.4]metacyclophanes to -theCorresponding syn- and anti Dithia[3.3] mdacyclophanes;Hisashi Fujihara等;《Heteroatom Chemistry》;19931231;第4卷(第5期);第488页scheme1 * |
Synthesis and properties of a vertically stacked porphyrin(1)-porphyrin(2)-quinone-cyclophane;Staab, Heinz A.等;《Angew.Chem.》;19941231;第106卷;第1532页右栏 * |
Vulcanization of Butadiene Rubber by Means of Cyclic Disulfides. 2.A2D Solid State HRMAS NMR Study on Cross-Link Structures in BRVulcanizates;Ron Hulst等;《Macromolecules》;19991231;第32卷;P7509-7520 * |
Also Published As
Publication number | Publication date |
---|---|
CN107501142A (en) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Codelli et al. | Second-generation difluorinated cyclooctynes for copper-free click chemistry | |
ATE514704T1 (en) | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | |
CN107501142B (en) | Restore chemical linkers and its preparation and purposes of the response type containing double disulfide bond | |
Vlahov et al. | Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part II: Folic acid conjugates of tubulysins and their hydrazides | |
CN108713020A (en) | The method for preparing antibody-rifamycin conjugate | |
CN109939242A (en) | Antibody prodrug conjugate and its preparation and application | |
Marquard et al. | Expanding the Scope of Antibody Rebridging with New Pyridazinedione–TCO Constructs | |
Yin et al. | Native conjugation between proteins and [60] fullerene derivatives using SpyTag as a reactive handle | |
JP7076433B2 (en) | New cytotoxic agents and their conjugates | |
Ogura et al. | Azaelectrocyclization on cell surface: convenient and general approach to chemical biology research | |
JP2021178855A (en) | Thioester prodrugs of macrocycles as inhibitors of histone deacetylases | |
JP7252333B2 (en) | Method for preparing antibody drug conjugate intermediate by acid method and its application | |
Gangemi et al. | Sulfoxides and disulfides from sulfenic acids: Synthesis and applications | |
Hartmann et al. | The Wittig bioconjugation of maleimide derived, water soluble phosphonium ylides to aldehyde-tagged proteins | |
Jadhav et al. | In silico design, synthesis, characterization and pharmacological evaluation of captopril conjugates in the treatment of renal fibrosis | |
Cserép et al. | Fluorogenic tagging of peptides via Cys residues using thiol-specific vinyl sulfone affinity tags | |
Cowling et al. | Attaching palladium catalysts to antibodies | |
CN114409563B (en) | Linker for protein labeling and application thereof in biological medicine | |
McLean et al. | Radical‐Mediated Acyl Thiol‐Ene Reaction for Rapid Synthesis of Biomolecular Thioester Derivatives | |
Ingallinella et al. | A new method for chemoselective conjugation of unprotected peptides to dauno-and doxorubicin | |
KR20140010517A (en) | Drug delivery complex enabling direct monitoring of delivery and cellular uptake of the drug and method for preparing the same | |
KR101375792B1 (en) | Derivatives Conjugated to Cell Penetrating Peptide and Uses Thereof | |
EP2974744A1 (en) | Strain-promoted oxidation controlled cycloaddition with high reaction rate | |
JP7038663B2 (en) | Conjugates and conjugate reagents containing a linker containing at least two (-CH2-CH2-0-) units in the ring | |
Knighton et al. | Synthesis and Reactivity of a Bis-Strained Alkyne Derived from 1, 1′-Biphenyl-2, 2′, 6, 6′-tetrol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |